Cargando…
Bridging non-human primate correlates of protection to reassess the Anthrax Vaccine Adsorbed booster schedule in humans
Anthrax Vaccine Adsorbed (AVA, BioThrax®) is approved for use in humans as a priming series of 3 intramuscular (i.m.) injections (0, 1, 6 months; 3-IM) with boosters at 12 and 18 months, and annually thereafter for those at continued risk of infection. A reduction in AVA booster frequency would less...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360524/ https://www.ncbi.nlm.nih.gov/pubmed/26072016 http://dx.doi.org/10.1016/j.vaccine.2015.05.091 |